EVH Overview

Stock Performance and Price Target Adjustments: Evolent Health Inc. has seen its price targets lowered by Citi and Canaccord, with current targets at $9.50 and $9 respectively, while both firms maintain a Buy rating amid increased uncertainty regarding the company's shares.

Q3 2025 Earnings Report: The company reported $480 million in Q3 revenue, achieving 8% sequential growth and maintaining its full-year revenue guidance between $1.87 and $1.88 billion, ending the quarter with $116.7 million in cash.

Future Revenue Contracts: Evolent Health has secured approximately $2.5 billion in revenue under contract for 2026, including new arrangements expected to contribute over $550 million, utilizing a new performance suite model.

Investment Considerations: While Evolent Health shows potential as an investment, there are suggestions that certain AI stocks may offer better upside potential and lower risk, prompting a recommendation to explore undervalued AI stocks.

Real-time Intelligence: Benzinga Pro offers traders the fastest news alerts to stay updated on market movements.

Exclusive Stories: The platform provides unique stories generated by Benzinga reporters, enhancing trading insights.

Community Engagement: Over 10,000 serious traders are part of the Benzinga Pro community, sharing knowledge and strategies.

Market Winning Tools: Benzinga Pro equips traders with essential tools and information to improve their market performance.

Real-time Intelligence: Benzinga Pro offers the fastest news alerts for traders, helping them stay informed and make timely decisions in the stock market.

Exclusive Content: Subscribers gain access to exclusive stories and insights generated by Benzinga reporters, enhancing their trading strategies.

Community of Traders: Over 10,000 serious traders are part of the Benzinga Pro community, sharing knowledge and experiences to improve their market performance.

Market Winning Tools: The platform provides tools and resources designed to help traders win in the markets every day.

Digital Health Market Growth: The global digital health market is projected to grow from USD 427.24 billion in 2025 to USD 1,500.69 billion by 2032, driven by advancements in AI and telecommunications, with North America holding a significant market share.

Aleen Inc.'s Smart Wellness Analytics: Aleen Inc. is testing a new Smart Wellness Analytics feature aimed at enhancing personal wellness awareness through AI-supported insights, focusing on user needs and privacy.

HEALWELL AI Inc. Strategic Transactions: HEALWELL AI Inc. has completed strategic transactions to streamline operations and focus on AI and software initiatives, transitioning to a pure-play digital SaaS company.

Evolent Health and AON Partnership: Evolent Health and American Oncology Network have announced a partnership to improve cancer care quality and affordability, eliminating prior authorization requirements for high-quality providers.